Program

Program Format

	Track 1: Breaking Genomics Research and Technology
These sessions will highlight cutting-edge research in areas such as human genomic Variation, Structural Biology and evolutionary genomics, and practical implications of genomics research. Experimental and computational approaches for effectively utilizing the latest DNA sequencing technologies will be presented during concurrent sessions.

	Track 2: System Biology
The section will focus on the symbiotic interplay between biology, technology, and computation of systems biology, hot topics include " proteomics", " genomics", "metabolomics" and "Signaling Networks" etc. Also speakers will provide the new ways in applying systems biology and systems theory to medicine.

	Track 3: RNA Biology
This section is design to cover covering the latest findings about RNA science, methodology, technology, and applications. Hot topics include Chemical Biology of RNA, Emerging Methodologies for RNA Science, RNA Structure and Folding, RNAs in Diseases, Therapeutic RNAs, Small RNAs etc.

	Track 4: Genome-based Drug Discovery and Gene Therapy
This section aims to bring together both industry and academia thought about emerging genome technical progress and its application in the development of new therapeutic understanding and novel compounds. Beside the concurrent sessions will highlights cutting edge research in the fields of gene and cell therapy.

	Track 5: Human Genetics, Genome and Diseases
This section will present a significant contribution to the advancement of human genetics of common disease, also devoted to the challenges of human genome variation studies and genetic Analysis.

	Track 6: Human Genomics and Personalized Medicine
This section will explore the fundamental, translational, and clinical sciences driving the progress of human genomics and personalized medicine movement.

	Track 7: Other Omics and Applications
This section aims to provide a comprehensive view of omics, such as the Emerging Proteomics, Metagenomics, Metabolomics, Transcriptomics, and Interactomics etc. It will present the studies from bench to data analysis together with early-stage experimental researchers and its latest development.

	Track 8: Non-Human Functional Genomics and Beyond
This session included comparative and functional genomics studies of several, diverse, animal and plant, hot area covers transgenic animal, forest functional genomics, fish and insect functional genomics.

Day one April 25th, 2012
09:00 – 09:40 am	Opening Ceremony and Welcome Remarks
10:00 – 12:30 am	Keynote Forum Ⅰ
01:30 – 05:30 pm	Keynote Forum Ⅱ
06:00 – 08:30 pm	Welcome Banquet and Performance

Session 6-1: Public Health Genomics Time: April 26, 2012, Thursday, 08:30-12:10 Place: Xi‘ an, China
Chair	*Dr. Matthias Harbers*, Chief Scientific Officer, Manager Global Marketing and Sales DNAFORM Inc., Japan
Co-Chair	*Dr. Nitin Patel*, Research Scientist, Keck School of Medicine of USC, USA
08:30-08:55	*Title:* Pharmacogenomics of Steroid Response in Eye *Dr. Nitin Patel*, Research Scientist, Keck School of Medicine of USC, USA
08:55-09:20	Title: How to Solve Genetic Disease on a Population Scale Dr. Barry Merriman, Lead System Architect, Advanced DNA Sequencing Technology, Life Technologies, Inc., USA
09:20-09:45	*Title:* Pharmacogenomics and Personalized Medicine: Considerations on Required Technologies Dr. Matthias Harbers, Chief Scientific Officer, Manager Global Marketing and Sales DNAFORM Inc., Japan
09:45-10:10	Speech Opportunity Available

Session 6-2: Whole Genome Sequencing and Clinical Diagnosis Time: April 26, 2012, Thursday, 13:30-17:10 Place: Xi’ an, China
Chair	Call for Host
Co-Chair	Call for Co-Host
13:30-13:55	Speech Opportunity Available
13:55-14:20	Title: TBD Dr. J.A. Rauwerda, Vascular Surgeon, VU University Medical Center, Amsterdam, The Netherlands
14:20-14:45	Title: Genome-wide Association Studies: Meta-analyzing Global Populations to Identify Common and Private Variants Dr. Yik-Ying TEO, Associate Professor, Head, Biostatistics Domain, Saw Swee Hock School of Public Health, National University of Singapore, Singapore
14:45-15:10	Speech Opportunity Available

Session 6-3: Mechanisms of Genomic Mutations Related Common and Rare Diseases Time: April 27, 2012, Friday, 08:30- 12:10 Place: Xi‘ an, China
Chair	Call for Host
08:30-08:55	Speech Opportunity Available
08:55-09:20	Title: Centromeres and Synthetic Chromatin States Dr. Alexander Kagansky, Senior Research Associate, University of Edinburgh/ Wellcome Trust Centre for Cell Biology, UK
09:20-09:45	Title: Genomic Deletions and Overlapping Clinical Phenotypes Dr. Goran Cuturilo, Professor, University Children’s Hospital, Faculty of Medicine, University of Belgrade, Serbia
09:45-10:10	Speech Opportunity Available

Session 6-4: Regulatory Variations and Mutations and Functions Time: April 27, 2012, Friday, 13:30-17:10 Place: Xi’ an, China
Chair	Call for Host
13:30-13:55	Speech Opportunity Available
13:55-14:20	Title: The Role of Epigenetic Regulation in Neurodevelopmental Disorders, Building Therapeutics Through Transcriptome Programming Dr. Christopher Wynder, Vice President of Research and Development, PTM Discoveries, Canada
14:20-14:45	Title: TBD Dr. Knut M. Wittkowski, Head, Biostatistics, Epidemiology, and Research Design, The Rockefeller University Hospital, General Clinical Research Center, USA
14:45-15:10	Speech Opportunity Available

Hosting Organizations

Information Research
Center of International Talent, SAFEA

China Council for the Promotion of
International Trade
Xi'an Sub-Council

China Medical Biotech Associatio

BIT Congress Inc.
Foreign Experts Databank
of SAFEA-Dalian Biotechnological
and Medical Experts Subdivision

BIT World Travel Service, Inc.